Clinical studies have shown normal insulin sensitivity, but reduced glucose-stimulated insulin secretion in subjects with pre-diabetes with HNF-4A MODY, suggesting that pancreatic β-cell dysfunction rather than insulin resistance is the primary defect in this disorder [15]. The gene discussed is HNF4A; the disease is Insulin resistance.